Who is sponsoring NCT00266539?

NCT00266539 is sponsored by Alza Corporation, DE, USA.

What condition does NCT00266539 study?

NCT00266539 studies Pain, Postoperative.

What drugs are being tested in NCT00266539?

Interventions: E-TRANS Fentanyl hydrochloride; Morphine.

What is the status of NCT00266539?

NCT00266539 is currently COMPLETED.

Last reviewed 2011-05-18 · How we verify

Comparison of the Safety and Efficacy of Patient Controlled Analgesia Delivered by Fentanyl HCl Transdermal System Versus Morphine IV Pump for Pain Management After Non-emergent Abdominal or Pelvic Surgery

NCT00266539 Phase 3 COMPLETED

The purpose of this study is to compare two pain medications delivered by two different forms of patient-controlled pain management systems: the Fentanyl HCl Patient-Controlled Transdermal System (E-TRANS fentanyl) and the morphine intravenous pump. Fentanyl HCl and morphine are narcotic pain relievers. The E-TRANS fentanyl system is a small unit worn on the patient's upper outer arm or chest that uses low-intensity electrical current to deliver fentanyl through the skin and into the patient's bloodstream. The patients studied will be those who have just had scheduled abdominal or pelvic surgery.

Details

Lead sponsor	Alza Corporation, DE, USA
Phase	Phase 3
Status	COMPLETED
Enrolment	506
Start date	2004-04
Completion	2005-04

Conditions

Pain, Postoperative

Interventions

E-TRANS Fentanyl hydrochloride; Morphine

Primary outcomes

Success (defined by a rating of "Excellent" or "Good") at the 24-hour patient global assessment of the method of pain control.